In previous papers the authors have described a combined technique for the assessment of analgesic and sedative drugs, and applied the method to a re-evaluation of pethidine and Pethilorfan. In this paper M.183, a new thebaine derivative with 6,000 times the molar potency of morphine, has been studied. It was found that in equipotent dosage this drug was as good an analgesic and sedative as morphine, with a shorter onset and duration of action. The degree of respiratory depression produced, however, was significantly greater and the incidence of unpleasant side effects was high. The advantages of the combined method of study have been demonstrated and will be applied to other new drugs as they become available.
In a recent study in which pethidine and a pethidine-levallorphan mixture (Pethilorfan) were re-evaluated, the authors concluded that the techniques employed to assess analgesic potency, sedation and the incidence of side effects with these established drugs might well be applied to new narcotics and sedatives (Campbell, Masson and Norris, 1965) . The present communication reports the results of an investigation into the properties of a new narcotic analgesic, M.183 ( fig. 1 ). This drug, a thebaine derivative, is one of a series first reported by Bentley and Hardy (1963) . A further report on the preliminary experimental pharmacological results, in animals, of this series was made by Lister (1964) . It was apparent from the initial studies in animals that these compounds varied greatly in analgesic potency compared with morphine sulphate, the range being from 0.1 to 8,000 times the molar potency of morphine.
M.183, with a molar potency of about 6,000 times that of morphine, appeared to be one of the more promising members of the series and preliminary studies in male volunteers were reported by Campbell, Lister and McNicol (1964) . Although this investigation demonstrated that M.183 was at least as depressant as morphine in assumed equianalgesic dosage, as far as respiratory function was concerned, it was also shown to have a quicker onset and shorter duration of action than morphine when given intravenously (duration of action of morphine : M183 = 2:1). It was therefore decided to examine the drug more closely in a limited clinical trial with particular reference to its analgesic and sedative properties and the incidence of respiratory depression and other unwanted side effects.
METHOD

Assessment oj analgesia.
Assessment of analgesia was carried out by the intravenous method described by Masson (1964) . Injections of the analgesic drugs were given intravenously to patients who had had a recent thoracotomy. Following injection, the patient was asked whether the pain was the same as before, slightly better, or much better. From previous animal experiments reported by Campbell, Lister and McNicol (1964) , it was considered that the equianalgesic dose of M.183 was 60 [j,g=mor-phine 10 mg, since the molar potency ratio in rats of M.183/morphine was 5,800:1. Accordingly, a double-blind trial was carried out using morphine 10 mg, M.183 30 ^g, and M.183 60 jxg. The results are shown in table I. These results suggest that M.183 is an effective analgesic in man. It also appears that M.183 30 (j.g produces less effective analgesia than either M.183 60 (ig or morphine 10 mg although, in the number of patients studied, it would be difficult to establish statistical significance. Finally, it seems that in man M.183 60 ^g is not more potent than morphine 10 mg and these doses would appear to be equipotent in terms of analgesic effect.
These findings are in accordance with the analgesic studies in rats referred to above.
The incidence of such side effects as drowsiness, nausea, and vomiting, was also recorded and these results are shown in table II. With M.183, eleven patients had no untoward side effects, four were drowsy and one was nauseated, while with morphine five had no side effects, one was drowsy, one was giddy, and one had retching.
Assessment of respiratory depression.
The method employed was based on that described by Campbell, Lister and McNicol (1964) , and again by Campbell, Masson and Norris (1965) , but only one post-drug measurement was practicable in the patients. A total of forty-eight female patients between the ages of 21 and 45, who were to undergo diagnostic uterine curettage but were otherwise healthy, were the subjects of this investigation. Grade I patients were selected according to the recommendations of the American Medical Association (A.M.A., 1954) . In order to gain some information on the dose response relationships of M.183 and morphine, two dose levels of each drug were used with saline as a control. A maximum concentration of 8 mg/ml of morphine was chosen because it was considered undesirable to exceed this level in a double-blind trial ( These drugs were made up in randomly numbered ampoules so that they could be administered in a dose of 1 ml/sq.m of body surface area for both high and low level doses. All drugs were given intravenously in this way on a doubleblind basis.
After a preliminary period breathing oxygen, the response to a respiratory challenge produced by breathing 5 per cent carbon dioxide/95 per cent oxygen mixture was measured before, and 15 minutes after the intravenous injection of the drug under test. In addition to measurements of minute volume and arterial carbon dioxide tension a subjective evaluation of the patient's condition was made by a trained observer, particular attention being paid to sedation, nausea or vomiting, histamine-like reaction at the injection site and changes in heart rate. The patient's spontaneous comments were also noted. Postoperatively, following a standardized anaesthetic technique employing thiopentone, nitrous oxide and oxygen, with minimal halothane, a repeat subjective assessment was made by the same trained observer. Table IV shows details of the data from the forty-eight subjects in terms of ages, height, weight and surface area. It must be re-emphasized that all patients were allocated drugs in a random fashion using the numbered ampoules previously described. In each section the mean values refer to the group as a whole.
RESULTS
The results of these respiratory studies are displayed in tables V and VI. It is evident from these findings that in equianalgesic dosage, at both dose levels chosen, and measuring at 15 minutes following intravenous injection, M.183 produced a significant decrease in alveolar ventilation whereas morphine did not. The incidence of other side effects is listed in tables VII and VIII. At the high dose level, i.e. 60 [xg/sq.m body surface area, M.183 caused a significant increase in arterial carbon dioxide tension from the control. No significant increase in arterial carbon dioxide tension was found with either dose of morphine or the lower dose of M.183.
There was a marked incidence of pre-operative and postoperative nausea and vomiting with both levels of M.183, in contrast to morphine. Only the higher incidence of pre-operative nausea with M.183 is significant (P<0.01). 
Measurement of sedation.
In order to evaluate the sedative efFects of M.183, one hundred otherwise healthy patients from the same gynaecological unit were studied. The patients were divided into four groups of 25, and each patient received one of the following injections: morphine 10 mg; M.183 60 pig; pethidine 60 mg; saline.
The injection was given intramuscularly 1 hour pre-operatively in a volume of 2 ml, the drugs being allocated in random fashion (in groups of eight) and the study being double-blind. Neither atropine nor hyoscine was administered at this time. An assessment of the presence or absence of anxiety and measurements of systemic blood pressure and heart rate were made in the ward on the day prior to anaesthesia. These were repeated in the anaesthetic room before and after applying a stimulus, so that a score of sedation was obtained (Nisbet and Norris, 1963) .
In previous studies patients scoring 0-4 were classed "poor", those scoring 5, 6 "fair", and those scoring 7-10 "good". Table IX shows the mean score and the standard deviation with each drug and saline, and the number of patients classed as "good", "fair" and "poor". The distri- fig. 2 ). Statistical evaluation of the results, using a "t" test to compare the means and a Chi-squared test to compare the "good", "fair" and "poor" groups was carried out and the results are shown in table X. From these figures it can be seen that M.183 60 (jig produced sedation indistinguishable from that produced by morphine 10 mg. Both drugs produced significantly better sedation than the control (saline) group. They also produced higher mean scores than pethidine 60 mg, although the differences with the numbers tested was not statistically significant. Both produced significantly more "good" results (P<0.02) than pethidine. While a study using larger numbers might show other significant differences between pethidine 60 mg and the other two drugs, this has not been carried out, but other work (Nisbet and Norris, 1963) , including unpublished work, suggests that pethidine 100 mg is equisedative to morphine 10 mg, and M.183 60 pig: pethidine 60 mg is the equianalgesic dose.
MORPHINE
In addition to studying the sedative effects of the drugs note was taken of any side effects during the trial. Twelve patients complained spontaneously of nausea or vomited in the anaesthetic room before induction of anaesthesia. The twelve were distributed thus: M.183, 6 cases; pethidine, 3 cases; saline, 2 cases; morphine, 1 case.
While it is now the practice to note nausea and vomiting occurring within the first 12 hours postoperatively, and to question the patient about nausea in the anaesthetic room, such records for this series are incomplete and are not included. Marked respiratory depression occurred in only one patient.
After thioptntone (2i per cent solution) 150 mg she became apnoeic, developed a laryngeal spasm and later started to breathe at a rate of two breaths per minute. This was satisfactorily reversed by nalorphine 10 mg administered intravenously. This patient had received M.183, 60 /»g.
Changes in arterial blood pressure and heart rate.
Changes in arterial blood pressure and heart rate are to be expected following the administration of a sedative drug, particularly when the drug has a hypnotic effect. Marked variations are undesirable and may contraindicate the use of the drug in certain patients. The systolic and diastolic blood pressure were measured by the usual indirect method. Changes from the reading taken in the ward on the day before operation to that obtained at rest in the anaesthetic room have been recorded. Similarly, changes in heart rate have been noted. Clearly emotion at the time of This study suggests that the use of Ml83 in common with the other drugs tested, produces minimal changes on the blood pressure and heart rate, if emotional changes are excluded.
DISCUSSION
In the first paper of this series, the theoretical advantages of this type of combined study of drug activity were discussed. In the second paper the results obtained when the method was applied to the re-evaluation of standard drugs were presented. It was also suggested that the same method could be profitably applied to the assessment of new analgesics and sedatives.
The present communication reports the results of a combined study of M.183, the first of a new series of narcotic analgesics. The advantages of the combined approach are amply demonstrated in this instance. While it had been shown that M183 was a safe and effective analgesic in animals and human volunteers, it remained to be evaluated and compared in greater detail with morphine in the clinical situation. This limited clinical trial showed that although M.183 is as good an analgesic and as effective a sedative, it is a more potent respiratory depressant than morphine in equianalgesic doses. A higher incidence of nausea and vomiting was produced and this latter finding was noted independently in two sections of the study. But for these findings of respiratory depression and other undesirable side effects in the combined study, M183 might well have been considered to have marginal advantages over morphine, since its analgesic and sedative effects were as good, and its duration of action was shorter.
Our search therefore continues for a drug with a higher ratio of analgesic potency/side effects, but to justify general use such a drug must have more than marginal advantages over morphine. The organizers would be grateful for suggestions as to the subjects that might be discussed on this occasion and they would be very pleased to receive offers of contributions for consideration before finalizing the programme.
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